How should constipation be managed safely in pregnant patients?

Management of Constipation in Pregnancy

Start with dietary fiber (approximately 30 g/day from fruits, vegetables, whole grains, and legumes) combined with adequate fluid intake, then escalate to polyethylene glycol or lactulose as first-line pharmacological therapy if dietary measures fail. 1

Stepwise Treatment Algorithm

First-Line: Dietary and Lifestyle Modifications

• Increase dietary fiber to 30 g/day through whole foods (fruits, vegetables, whole grains, legumes) 1
• Ensure adequate fluid intake, particularly water, to soften stools 1
• Encourage patients to avoid straining by allowing ample time for bowel movements and using relaxation techniques 1

Clinical Context: Constipation affects 20-40% of pregnant patients, driven primarily by elevated progesterone levels that slow GI motility 1. The gravid uterus compresses the rectum, particularly in the third trimester, further exacerbating symptoms 1.

Second-Line: Bulk-Forming Agents

If dietary measures are insufficient:

• Psyllium husk or methylcellulose are safe due to lack of systemic absorption 1
• Soluble fiber (like psyllium) is superior to insoluble fiber as it improves both stool viscosity and transit time, not just bulk 1

Caution: Excessive fiber can cause maternal bloating 1

Third-Line: Osmotic Laxatives

When bulk-forming agents fail:

• Polyethylene glycol (PEG) 17 g daily or lactulose 15 g daily 1, 2
• Both are safe throughout pregnancy with no systemic absorption concerns 1
• Lactulose is the only osmotic agent specifically studied in pregnancy 2
• Recent evidence shows PEG may work faster than lactulose (significant improvement by week 2 vs week 3) without inducing diarrhea 3, 4

Practical Consideration: While both are equally effective ultimately, PEG may provide quicker symptom relief and causes less bloating than lactulose 4. However, lactulose has more pregnancy-specific safety data 2.

Caution: Both can cause maternal bloating, particularly lactulose at higher doses 1. Magnesium oxide should be used with caution in pregnancy and avoided in renal insufficiency 2.

What to Avoid

Stimulant laxatives (bisacodyl, senna) should be avoided as primary therapy because safety data in pregnancy are conflicting and long-term safety/efficacy remain unknown 1, 2. These may be considered only for short-term rescue therapy if other options fail 2.

Management of Associated Hemorrhoids

Approximately 80% of pregnant patients develop hemorrhoids, especially in the third trimester 1. Hydrocortisone foam is safe in the third trimester based on a prospective study of 204 patients showing no adverse events compared to placebo 1.

Common Pitfalls to Avoid

1. Don't dismiss subjective symptoms: Some patients with objective constipation (high assessment scores) may not report symptoms, while others with lower scores are highly symptomatic 3

2. Don't undertreat early: 60% of patients with pre-pregnancy constipation will have persistent constipation during pregnancy and postpartum 3

3. Don't use stimulant laxatives routinely: Reserve these for rescue therapy only due to unclear pregnancy safety profiles 1

4. Don't forget hydration: Increasing fiber without adequate fluids can worsen symptoms 1

Evidence Quality

The 2024 AGA Clinical Practice Update 1 provides the most current and authoritative guidance specific to pregnancy-related constipation, explicitly recommending dietary fiber, lactulose, and PEG-based laxatives. This supersedes older general constipation guidelines that lack pregnancy-specific considerations. The recommendation to avoid stimulant laxatives is consistent across both pregnancy-specific 1 and general constipation guidelines 2.